1
|
Zheng W, Liu H, Li Z, Li K, Wang Y, Hu B, Dong Q, Wang Z. Classification of Alzheimer's disease based on hippocampal multivariate morphometry statistics. CNS Neurosci Ther 2023; 29:2457-2468. [PMID: 37002795 PMCID: PMC10401169 DOI: 10.1111/cns.14189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Revised: 03/07/2023] [Accepted: 03/13/2023] [Indexed: 08/05/2023] Open
Abstract
BACKGROUND Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive decline, and mild cognitive impairment (MCI) is associated with a high risk of developing AD. Hippocampal morphometry analysis is believed to be the most robust magnetic resonance imaging (MRI) markers for AD and MCI. Multivariate morphometry statistics (MMS), a quantitative method of surface deformations analysis, is confirmed to have strong statistical power for evaluating hippocampus. AIMS We aimed to test whether surface deformation features in hippocampus can be employed for early classification of AD, MCI, and healthy controls (HC). METHODS We first explored the differences in hippocampus surface deformation among these three groups by using MMS analysis. Additionally, the hippocampal MMS features of selective patches and support vector machine (SVM) were used for the binary classification and triple classification. RESULTS By the results, we identified significant hippocampal deformation among the three groups, especially in hippocampal CA1. In addition, the binary classification of AD/HC, MCI/HC, AD/MCI showed good performances, and area under curve (AUC) of triple-classification model achieved 0.85. Finally, positive correlations were found between the hippocampus MMS features and cognitive performances. CONCLUSIONS The study revealed significant hippocampal deformation among AD, MCI, and HC. Additionally, we confirmed that hippocampal MMS can be used as a sensitive imaging biomarker for the early diagnosis of AD at the individual level.
Collapse
Affiliation(s)
- Weimin Zheng
- Department of Radiology, Aerospace Center Hospital, Beijing, China
| | - Honghong Liu
- School of Medical Technology, Beijing Institute of Technology, Beijing, China
| | - Zhigang Li
- School of Medical Technology, Beijing Institute of Technology, Beijing, China
| | - Kuncheng Li
- Department of Radiology, Xuanwu Hospital of Capital Medical University, Beijing, China
| | - Yalin Wang
- School of Computing, Informatics, and Decision Systems Engineering, Arizona State University, Tempe, Arizona, USA
| | - Bin Hu
- School of Medical Technology, Beijing Institute of Technology, Beijing, China
| | - Qunxi Dong
- School of Medical Technology, Beijing Institute of Technology, Beijing, China
| | - Zhiqun Wang
- Department of Radiology, Aerospace Center Hospital, Beijing, China
| |
Collapse
|
2
|
Shi Y, Wang Z, Chen P, Cheng P, Zhao K, Zhang H, Shu H, Gu L, Gao L, Wang Q, Zhang H, Xie C, Liu Y, Zhang Z. Episodic Memory-Related Imaging Features as Valuable Biomarkers for the Diagnosis of Alzheimer's Disease: A Multicenter Study Based on Machine Learning. BIOLOGICAL PSYCHIATRY. COGNITIVE NEUROSCIENCE AND NEUROIMAGING 2023; 8:171-180. [PMID: 33712376 DOI: 10.1016/j.bpsc.2020.12.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2020] [Revised: 12/16/2020] [Accepted: 12/16/2020] [Indexed: 10/22/2022]
Abstract
BACKGROUND Individualized and reliable biomarkers are crucial for diagnosing Alzheimer's disease (AD). However, lack of accessibility and neurobiological correlation are the main obstacles to their clinical application. Machine learning algorithms can effectively identify personalized biomarkers based on the prominent symptoms of AD. METHODS Episodic memory-related magnetic resonance imaging (MRI) features of 143 patients with amnesic mild cognitive impairment (MCI) were identified using a multivariate relevance vector regression algorithm. The support vector machine classification model was constructed using these MRI features and verified in 2 independent datasets (N = 994). The neurobiological basis was also investigated based on cognitive assessments, neuropathologic biomarkers of cerebrospinal fluid, and positron emission tomography images of amyloid-β plaques. RESULTS The combination of gray matter volume and amplitude of low-frequency fluctuation MRI features accurately predicted episodic memory impairment in individual patients with amnesic MCI (r = 0.638) when measured using an episodic memory assessment panel. The MRI features that contributed to episodic memory prediction were primarily distributed across the default mode network and limbic network. The classification model based on these features distinguished patients with AD from normal control subjects with more than 86% accuracy. Furthermore, most identified episodic memory-related regions showed significantly different amyloid-β positron emission tomography measurements among the AD, MCI, and normal control groups. Moreover, the classification outputs significantly correlated with cognitive assessment scores and cerebrospinal fluid pathological biomarkers' levels in the MCI and AD groups. CONCLUSIONS Neuroimaging features can reflect individual episodic memory function and serve as potential diagnostic biomarkers of AD.
Collapse
Affiliation(s)
- Yachen Shi
- Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Institution of Neuropsychiatry, Southeast University, Nanjing, China
| | - Zan Wang
- Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Institution of Neuropsychiatry, Southeast University, Nanjing, China
| | - Pindong Chen
- Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China; University of Chinese Academy of Sciences, Beijing, China
| | - Piaoyue Cheng
- Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Institution of Neuropsychiatry, Southeast University, Nanjing, China
| | - Kun Zhao
- Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China; School of Biological Science and Medical Engineering, Beihang University, Beijing, China
| | - Hongxing Zhang
- Department of Psychology, Xinxiang Medical University, Xinxiang, China; Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China
| | - Hao Shu
- Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Institution of Neuropsychiatry, Southeast University, Nanjing, China
| | - Lihua Gu
- Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Institution of Neuropsychiatry, Southeast University, Nanjing, China
| | - Lijuan Gao
- Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Institution of Neuropsychiatry, Southeast University, Nanjing, China
| | - Qing Wang
- Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Institution of Neuropsychiatry, Southeast University, Nanjing, China
| | - Haisan Zhang
- Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China
| | - Chunming Xie
- Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Institution of Neuropsychiatry, Southeast University, Nanjing, China
| | - Yong Liu
- Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China; Center for Excellence in Brain Science and Intelligence Technology, Institute of Automation, Chinese Academy of Sciences, Beijing, China; University of Chinese Academy of Sciences, Beijing, China; School of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China.
| | - Zhijun Zhang
- Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Institution of Neuropsychiatry, Southeast University, Nanjing, China; School of Life Science and Technology, The Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China; Department of Psychology, Xinxiang Medical University, Xinxiang, China; Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
| | | |
Collapse
|
4
|
Wang W, Cao D, Li X, Cao N. Compressively sampled magnetic resonance imaging reconstruction based on split Bregman iteration with general non-uniform threshold shrinkage. Magn Reson Imaging 2021; 85:297-307. [PMID: 34666160 DOI: 10.1016/j.mri.2021.10.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Revised: 09/08/2021] [Accepted: 10/12/2021] [Indexed: 10/20/2022]
Abstract
PURPOSE K-space under-sampling reconstruction technology is an effective means to improve the speed of magnetic resonance imaging. Among its many reconstruction algorithms, split Bregman iteration is an effective method to solve multi-constrained models. This model often contains TV variational regularization terms, the generalized threshold shrinkage operator often used to solve TV constraints subproblem. However, when the generalized threshold shrinkage operator is performing the shrinking operation, it does not consider the inconsistency of the elements in the image matrix, which will cause the loss of image details. METHODS In response to this problem, in this paper, a non-uniform threshold shrinkage operator was proposed to solve above TV constraints subproblem, which can dynamically adjust the shrinkage threshold by the residuals of each image element. And introduce this operator when performing Split Bregman iteration to improve the performance of generalized threshold shrinkage. RESULTS After qualitative and quantitative analysis during the experiments, it can be concluded that compared with the other three methods, the proposed method has better performance in terms of Peak Signal to Noise Ratio (PSNR), Structural Similarity Index Measure (SSIM), Transferred Edge Information(TEI) and Normalized Mutual Information(NMI), and the visual perception is better. Then we also did denoising performance analysis at different noise levels, this method also showed good robustness. CONCLUSIONS The proposed method can improve the reconstruction performance of TV constrained subproblem in split Bregman iteration, and then improve the overall performance of reconstruction algorithm. Moreover, this method also shows good denoising performance at different noise levels.
Collapse
Affiliation(s)
- Wei Wang
- Key Lab of Clinical Engineering, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China
| | - Da Cao
- Key Lab of Clinical Engineering, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China; Department of Radiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - Xiuhan Li
- Key Lab of Clinical Engineering, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China
| | - Ning Cao
- School of Computer and Information, Hohai University, Nanjing, Jiangsu 210098, China.
| |
Collapse
|
5
|
Prins S, Zhuparris A, Hart EP, Doll RJ, Groeneveld GJ. A cross-sectional study in healthy elderly subjects aimed at development of an algorithm to increase identification of Alzheimer pathology for the purpose of clinical trial participation. ALZHEIMERS RESEARCH & THERAPY 2021; 13:132. [PMID: 34274005 PMCID: PMC8286577 DOI: 10.1186/s13195-021-00874-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/11/2021] [Accepted: 07/04/2021] [Indexed: 11/10/2022]
Abstract
Background In the current study, we aimed to develop an algorithm based on biomarkers obtained through non- or minimally invasive procedures to identify healthy elderly subjects who have an increased risk of abnormal cerebrospinal fluid (CSF) amyloid beta42 (Aβ) levels consistent with the presence of Alzheimer’s disease (AD) pathology. The use of the algorithm may help to identify subjects with preclinical AD who are eligible for potential participation in trials with disease modifying compounds being developed for AD. Due to this pre-selection, fewer lumbar punctures will be needed, decreasing overall burden for study subjects and costs. Methods Healthy elderly subjects (n = 200; age 65–70 (N = 100) and age > 70 (N = 100)) with an MMSE > 24 were recruited. An automated central nervous system test battery was used for cognitive profiling. CSF Aβ1-42 concentrations, plasma Aβ1-40, Aβ1-42, neurofilament light, and total Tau concentrations were measured. Aβ1-42/1-40 ratio was calculated for plasma. The neuroinflammation biomarker YKL-40 and APOE ε4 status were determined in plasma. Different mathematical models were evaluated on their sensitivity, specificity, and positive predictive value. A logistic regression algorithm described the data best. Data were analyzed using a 5-fold cross validation logistic regression classifier. Results Two hundred healthy elderly subjects were enrolled in this study. Data of 154 subjects were used for the per protocol analysis. The average age of the 154 subjects was 72.1 (65–86) years. Twenty-four (27.3%) were Aβ positive for AD (age 65–83). The results of the logistic regression classifier showed that predictive features for Aβ positivity/negativity in CSF consist of sex, 7 CNS tests, and 1 plasma-based assay. The model achieved a sensitivity of 70.82% (± 4.35) and a specificity of 89.25% (± 4.35) with respect to identifying abnormal CSF in healthy elderly subjects. The receiver operating characteristic curve showed an AUC of 65% (± 0.10). Conclusion This algorithm would allow for a 70% reduction of lumbar punctures needed to identify subjects with abnormal CSF Aβ levels consistent with AD. The use of this algorithm can be expected to lower overall subject burden and costs of identifying subjects with preclinical AD and therefore of total study costs. Trial registration ISRCTN.org identifier: ISRCTN79036545 (retrospectively registered). Supplementary Information The online version contains supplementary material available at 10.1186/s13195-021-00874-9.
Collapse
Affiliation(s)
- Samantha Prins
- Centre for Human drug Research, Leiden, the Netherlands.,Leiden University Medical Center, Leiden, the Netherlands
| | | | - Ellen P Hart
- Centre for Human drug Research, Leiden, the Netherlands
| | | | - Geert Jan Groeneveld
- Centre for Human drug Research, Leiden, the Netherlands. .,Leiden University Medical Center, Leiden, the Netherlands.
| |
Collapse
|